DYAI
Dyadic InternationalยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
DYAI Profile
Dyadic International, Inc.
A global biotech company that develops enzymes and other proteins for bioenergy, bio-basedhemicals, and biopharmaceuticals
1044 North U.S, Highway One, Suite 201 , Jupiter, Florida 33477
--
Dyadic International, Inc., was incorporated in Delaware in September 2002. The company is a global biotechnology platform company headquartered in Jupiter, Florida, with operations in the United States, a satellite office in the Netherlands, and corporate activities utilizing multiple third-party consultants and research organizations. Over the past two decades, the company has developed a gene expression platform for the production of commercial quantities of industrial enzymes and proteins, and has previously licensed the technology to third parties such as Abengoa Bioenergy SA, BASF SE, Codexis, Inc., for industrial applications. This technology is based on the Thermothelomyces heterothallica fungus named C1 by the company.
